Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors

[1]  Jeffrey E Gershenwald,et al.  Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[2]  D. Elder,et al.  Update on Thin Melanoma: Outcome of an International Workshop , 2016, Advances in anatomic pathology.

[3]  R. Scolyer,et al.  Data Set for Pathology Reporting of Cutaneous Invasive Melanoma , 2013, The American journal of surgical pathology.

[4]  J. Aitken,et al.  Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Hofmann-Wellenhof,et al.  Agreement of Dermatopathologists in the Evaluation of Clinically Difficult Melanocytic Lesions: How Golden Is the ‘Gold Standard’? , 2012, Dermatology.

[6]  E. Glusac.  The melanoma ‘epidemic’: lessons from prostate cancer , 2012, Journal of cutaneous pathology.

[7]  M. Shoup,et al.  Predictors of positive sentinel lymph node in thin melanoma. , 2011, American journal of surgery.

[8]  M. Mihm,et al.  The performance of MelaFind: a prospective multicenter study. , 2011, Archives of dermatology.

[9]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Scolyer,et al.  Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma , 2009, Annals of surgery.

[11]  D. Elder,et al.  Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Simon Davies,et al.  Epidemiology: Study Design and Data Analysis , 2006 .

[13]  G. Cumming,et al.  Inference by eye: confidence intervals and how to read pictures of data. , 2005, The American psychologist.

[14]  Sing Kai Lo,et al.  Interobserver Reproducibility of Histopathologic Prognostic Variables in Primary Cutaneous Melanomas , 2003, The American journal of surgical pathology.

[15]  D. Tyler,et al.  Thin Melanomas: Predictive Lethal Characteristics From a 30-Year Clinical Experience , 2003, Annals of surgery.

[16]  W. McCarthy,et al.  Prognosis for patients with thin cutaneous melanoma , 2003, Cancer.

[17]  H. Olsson,et al.  Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review , 2001, Melanoma research.

[18]  John O'Quigley,et al.  An application of changepoint methods in studying the effect of age on survival in breast cancer , 1999 .

[19]  C. Garbe,et al.  Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. , 1997, Journal of clinical epidemiology.

[20]  R. Simon,et al.  A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. , 1996, Statistics in medicine.

[21]  G. Clark,et al.  Practical p-value adjustment for optimally selected cutpoints. , 1996, Statistics in medicine.

[22]  Gernot Rassner,et al.  Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients , 1995, Cancer.

[23]  W. Sauerbrei,et al.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.

[24]  U. Ringborg,et al.  Prognostic factors in thin cutaneous malignant melanoma , 1994, Cancer.

[25]  R. MacKie,et al.  The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. , 1991, British Journal of Cancer.

[26]  S. McCarthy,et al.  Thin malignant melanomas and recurrence potential. , 1987, Archives of surgery.

[27]  C. Balch,et al.  The prognostic significance of ulceration of cutaneous melanoma , 1980, Cancer.

[28]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.

[29]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[30]  Simon Davies,et al.  Epidemiology: Study Design and Data Analysis (2nd ed.) , 2006 .

[31]  W. McGuire,et al.  Why do so many prognostic factors fail to pan out? , 2005, Breast Cancer Research and Treatment.

[32]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.